Theoretically, associations found in cohort studies could be confounded if serum IGF-I levels were affected by IGF-I being produced in the tumour itself, but this would be extremely unlikely due to the known dynamics of the systemic IGF-system and the evidence in humans confirms that this is generally not the case. Here, IGF1 is linked to neoplasm.